BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND DDX6, P54, 1656, ENSG00000110367, HLR2, P26196, RCK, FLJ36338 AND Treatment
4 results:

  • 1. Predicting Risk of Recurrence After colorectal cancer Surgery in the United States: An Analysis of a Special Commission on cancer National Study.
    Zafar SN; Hu CY; Snyder RA; Cuddy A; You YN; Lowenstein LM; Volk RJ; Chang GJ
    Ann Surg Oncol; 2020 Aug; 27(8):2740-2749. PubMed ID: 32080809
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pedunculated Morphology of T1 colorectal Tumors Associates With Reduced Risk of Adverse Outcome.
    Kessels K; Backes Y; Elias SG; van den Blink A; Offerhaus GJA; van Bergeijk JD; Groen JN; Seerden TCJ; Schwartz MP; de Vos Tot Nederveen Cappel WH; Spanier BWM; Geesing JMJ; Kerkhof M; Siersema PD; Didden P; Boonstra JJ; Herrero LA; Wolfhagen FHJ; Ter Borg F; van Lent AU; Terhaar Sive Droste JS; Hazen WL; Schrauwen RWM; Vleggaar FP; Laclé MM; Moons LMG;
    Clin Gastroenterol Hepatol; 2019 May; 17(6):1112-1120.e1. PubMed ID: 30130623
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Laparoscopy in the surgical treatment of rectal cancer in Germany 2000-2009.
    Mroczkowski P; Hac S; Smith B; Schmidt U; Lippert H; Kube R
    Colorectal Dis; 2012 Dec; 14(12):1473-8. PubMed ID: 22540837
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Sphinganine causes early activation of JNK and p38 MAPK and inhibition of AKT activation in HT-29 human colon cancer cells.
    Ahn EH; Schroeder JJ
    Anticancer Res; 2006; 26(1A):121-7. PubMed ID: 16475687
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.